#USA #Arlington #diagnostics #IVD Market #Kalorama Information

Kalorama Information's 2025 IVD Market Atlas

Kalorama Information, a renowned leader in healthcare market intelligence, recently released its 30-Country IVD Market Atlas for 2025, offering an extensive analysis of the in vitro diagnostics (IVD) market across thirty nations. This update is part of their continuous effort to deliver timely insights and data, containing detailed reports that are essential for understanding the evolving global landscape.

Key Features of the Report

The 2025 report provides granular market sizing, forecasts until 2029, and covers over twenty critical IVD categories. These categories include:

• - Molecular diagnostics (like HIV, Hepatitis, and Respiratory infections)
• - Point-of-Care (POC) testing (Pregnancy tests, Glucose monitoring, infectious disease tests)
• - Immunoassays, Coagulation, Hematology, Histology
• - Microbiology and Core Lab/Critical Care

Unlike fragmented sources of information, this atlas serves as a single, consistent reference for understanding demand, regulatory environments, and competitive landscapes, making it perfect for strategic planning, product launches, and market expansion.

Highlights from the June Update

According to the latest data, China stands out as the fastest-growing market for IVD products among the tracked countries, expected to achieve a remarkable compound annual growth rate (CAGR) of nearly 9% through 2029. This growth is almost four times greater compared to slower markets like Egypt, Russia, and Japan. Daniel Granderson, Senior Editor at Kalorama Information, notes, "China is a critical target for major vendors seeking growth amid stagnation in developed regions. In 2024, glucose monitoring alone made up over 20% of China's IVD value, and this trajectory is just beginning."

Additional countries forecasted to exceed a 5% CAGR include Saudi Arabia, South Korea, Turkey, Vietnam, and the UAE. This growth is propelled by increasing access to healthcare, rising chronic disease rates, and advancements in technology. However, Russia's IVD market has seen negative trends due to the exodus of foreign companies amid the ongoing Ukraine crisis.

The rise of AI technology, home testing options, and personalized medicine are also playing significant roles in redefining how diagnostics are delivered across various regions.

Who Can Benefit from This Report?

The 30-Country IVD Market Atlas is essential reading for:

• - Executive leadership and strategic planners in diagnostic and medtech organizations
• - Product and portfolio managers making critical localization decisions
• - Business development teams looking for merger and acquisition opportunities
• - Investors and financial analysts assessing potential growth in specific countries
• - Regulatory professionals keeping up with compliance and approval trends

How to Access the Full Report

To delve deeper into these insights, access the full report, or schedule a custom consultation, visit Kalorama Information's website. For custom research or enterprise access, reach out to Sheri Davie, Sales Director at Kalorama Information. For media inquiries, contact Richa Singh, Vice President of Strategic Insights Sales at the same organization.

About Kalorama Information

Kalorama Information, a division of the Science and Medicine Group, has over twenty-five years of experience as a leading provider of healthcare market research. The company's analysts focus on IVD, biotechnology, medical devices, and pharmaceuticals. Known for their flagship report, The Worldwide Market for In Vitro Diagnostic Tests, Kalorama maintains close collaboration with other SMG brands, thus providing extensive insight into diagnostics, life sciences, and imaging markets. To explore more, visit www.kaloramainformation.com.